Adocia Stock BOERSE MUENCHEN
Stocks
A89
FR0011184241
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.134 EUR | -0.48% |
|
-1.14% | -36.58% |
| 06-08 | Adocia presents Phase 3 study data |  |
| 06-08 | Adocia Presents Full Phase 3 Results For BioChaperone Lispro In Type 2 Diabetes Presented at ADA 86th Scientific Sessions | CI |
| Market Cap | 81.16M 93.14M 74.81M 70.37M 132M 8.78B 133M 890M 346M 4.33B 350M 342M 14.99B | P/E 2025 |
-7.44x | P/E 2026 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise Value | 38.63M 44.34M 35.61M 33.5M 62.67M 4.18B 63.11M 424M 165M 2.06B 166M 163M 7.14B | EV / Sales 2025 |
31.9x | EV / Sales 2026 * | 0.84x |
| Free-Float |
90.83% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 week | -1.14% | ||
| Current month | -15.94% | ||
| 1 month | -14.53% | ||
| 3 months | -26.61% | ||
| 6 months | -35.70% | ||
| Current year | -36.58% |
| 1 week | 4.13 |  | 4.61 |
| 1 month | 3.95 | | 5.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
Olivier Soula
CEO | Chief Executive Officer | 55 | 2023-05-10 |
| Director of Finance/CFO | - | 2024-09-22 | |
Martin Gaudier
CTO | Chief Tech/Sci/R&D Officer | - | 2014-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Olivier Soula
BRD | Director/Board Member | 55 | 2013-04-18 |
Gérard Soula
CHM | Chairman | 80 | 2012-02-23 |
| Director/Board Member | 58 | 2013-06-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.48% | -1.14% | +7.20% | - | 93.14M | |
| +0.66% | -2.23% | +61.90% | +112.75% | 54.44B | |
| +4.60% | +5.82% | +56.35% | +43.04% | 45.8B | |
| -1.44% | +1.51% | -12.94% | -19.24% | 22.98B | |
| -2.69% | -0.95% | -3.68% | +379.00% | 20.76B | |
| +3.22% | +2.94% | +24.02% | -35.05% | 16.25B | |
| +1.20% | +0.65% | +14.86% | -39.22% | 15.34B | |
| -1.01% | -2.97% | +27.42% | +171.92% | 13.05B | |
| +3.07% | +5.43% | +21.37% | - | 12.37B | |
| +4.95% | +13.49% | +121.11% | +249.05% | 12.47B | |
| Average | +1.39% | +2.19% | +31.76% | +107.78% | 23.72B | |
| Weighted average by Cap. | +1.43% | +1.38% | +38.99% | +98.03% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 38.39M 44.06M 35.39M 33.29M 62.28M 4.15B 62.72M 421M 164M 2.05B 165M 162M 7.09B | 38.39M 44.06M 35.39M 33.28M 62.27M 4.15B 62.71M 421M 164M 2.05B 165M 162M 7.09B |
| Net income | -13.01M -14.94M -12M -11.28M -21.11M -1.41B -21.26M -143M -55.43M -694M -56.07M -54.86M -2.4B | 3.98M 4.56M 3.67M 3.45M 6.45M 430M 6.5M 43.61M 16.94M 212M 17.13M 16.76M 735M |
| Net Debt | -42.52M -48.8M -39.2M -36.87M -68.98M -4.6B -69.46M -466M -181M -2.27B -183M -179M -7.86B | -48.77M -55.97M -44.95M -42.28M -79.1M -5.27B -79.66M -535M -208M -2.6B -210M -206M -9.01B |
| Date | Price | Change |
|---|---|---|
| 26-06-19 | 4.134 € | -0.48% |
| 26-06-18 | 4.154 € | -2.85% |
| 26-06-17 | 4.276 € | -3.48% |
| 26-06-16 | 4.430 € | 0.00% |
| 26-06-15 | 4.430 € | +3.17% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADOC Stock
- A89 Stock
Select your edition
All financial news and data tailored to specific country editions
